← Open Payments lookup

MICHAEL ENG: Open Payments

NPI 1053882076 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,406 in 124 payments from 40 companies in 2025. Trend: 2023 $0 · 2024 $3,090 · 2025 $3,406

Food & beverage: $3,328Education: $78
CompanyPaymentsAmount
Merck Sharp & Dohme LLC10$284
Novartis Pharmaceuticals Corporation11$278
AstraZeneca Pharmaceuticals LP9$255
Janssen Biotech, Inc.8$206
Incyte Corporation7$190
SOBI, INC6$144
Daiichi Sankyo Inc.5$134
GENZYME CORPORATION5$130
Eisai Inc.5$112
Karyopharm Therapeutics Inc.4$108

Products named: ENHERTU, KEYTRUDA, JAKAFI, IMFINZI, PLUVICTO, Lenvima, XPOVIO, SARCLISA.

Industry payments across CA — which companies pay providers there.